GE HealthCare and Foundations Pledge $1M to Enhance Milwaukee Health Outcomes
GE HealthCare (Nasdaq: GEHC), the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation (CAFF) have joined forces to introduce a new philanthropic initiative called Powering Milwaukee Forward. This program is designed to enhance access to essential resources in Milwaukee’s…
Genentech’s Vabysmo Enhances Vision in Underrepresented DME Populations
Genentech, part of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today encouraging topline results from the one-year Phase IV ELEVATUM study. This open-label, single-arm trial evaluated Vabysmo® (faricimab-svoa) for treating diabetic macular edema (DME) in individuals from racial…
Peach State Health Plan and Centene Foundation Donate $100,000 for Hurricane Relief in Georgia
Peach State Health Plan, a Georgia-based care management organization, and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC), have announced a $100,000 donation to support hurricane relief efforts in Georgia following Hurricanes Helene and Milton. The funds…
David Joyner Named President and CEO of CVS Health
CVS Health (NYSE: CVS) has named David Joyner as President and Chief Executive Officer, effective October 17, succeeding Karen Lynch, who stepped down in agreement with the Board of Directors. Joyner also joins the Board, while Roger Farah transitions to…
Aetna Launches SimplePay Health
Aetna, a CVS Health company (NYSE: CVS), has introduced SimplePay Health, a new health plan tailored for self-insured clients. This plan aims to reduce costs, enhance health outcomes, and streamline the healthcare experience with a unique approach to coverage. SimplePay…
Evidation Teams with 1upHealth to Integrate Real-World Health Data for Research
Evidation, a leader in measuring and enhancing everyday health, has announced a long-term partnership with 1upHealth, a top provider of FHIR® platform solutions for claims and clinical data interoperability. This collaboration aims to advance patient-centered real-world health research by facilitating…
DIA Canada Annual Meeting Focuses on Precision Regulation and Clinical Trial Advances
DIA, a global non-profit organization for life sciences professionals, will host discussions on Canada’s precision regulation initiatives, the enhancement of its clinical trial infrastructure, and international collaboration at the Canada Annual Meeting on November 14-15 in Gatineau, Quebec. Health Canada…
Palomar Health Partners with IKS Health for Holistic Healthcare Transformation
Palomar Health, a prominent healthcare system in North San Diego County, CA, has formed a multi-year partnership with IKS Health, a provider of technology-enabled healthcare solutions. This collaboration aims to harness advanced technology, including Gen AI, to support Palomar Health…
Nordic Group Launches LACRIFILL® Canalicular Gel for Dry Eye at 2024 AAO
Nordic Pharma, Inc., a subsidiary of Nordic Group BV, introduced LACRIFILL Canalicular Gel, an innovative therapy for dry eye, in the U.S. this April and is showcasing it to leading ophthalmologists at AAO 2024. This cross-linked hyaluronic acid gel, approved…
Tasso Survey: One in Three Patients Delay Blood Tests Due to Anxiety and Pain
Tasso, Inc., a leader in patient-centric blood collection solutions, recently surveyed over 600 U.S. adults aged 18 and older to explore their experiences and preferences regarding blood testing. The survey, titled Patient Preferences, Perceptions, and the Evolving Challenges of Ensuring…
Luminate Health Dominates Direct-to-Consumer Lab Testing Market
Luminate Health, a leader in healthcare technology for the clinical laboratory and diagnostics sector, is achieving remarkable success with its Direct-to-Consumer (DTC) lab testing platform. This innovative service allows commercial and hospital laboratories to connect directly with patients, enhancing accessibility…
Merck’s Clesrovimab Reduces RSV Disease and Hospitalization in Infants
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, recently shared encouraging outcomes from its Phase 2b/3 clinical trial (MK-1654-004) of clesrovimab, a monoclonal antibody aimed at preventing respiratory syncytial virus (RSV) in infants. The findings were presented…